IP Library Patent Application 13705833
Patent Application
App. No. 13/705,833

IN VITRO EVOLUTION IN MICROFLUIDIC SYSTEMS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/705,833
Abstract

The invention describes a method for isolating one or more genetic elements encoding a gene product having a desired activity, comprising the steps of: (a) compartmentalising genetic elements into microcapsules; and (b) sorting the genetic elements which express the gene product having the desired activity; wherein at least one step is under microfluidic control. The invention enables the in vitro evolution of nucleic acids and proteins by repeated mutagenesis and iterative applications of the method of the invention.

Claims (18)

1 - 107 . (canceled)

108 . A method for preparing an entity for analysis, the method comprising:

obtaining a first fluid comprising a plurality of entities; and

forming droplets of the first fluid, each comprising multiple copies of a subset of said plurality, in a channel that contains droplets of a second fluid flowing in a third fluid, wherein the first, second, and third fluids are immiscible with each other.

109 . The method according to claim 108 , wherein the first fluid is an aqueous fluid and the second and third fluids are different oils.

110 . The method according to claim 109 , wherein the third fluid is a fluorinated or perfluorinated oil.

111 . The method according to claim 108 , wherein the droplets of the first fluid are separated by droplets of the second fluid.

112 . The method according to claim 108 , wherein the entities are nucleic acids, proteins, or cells.

113 . The method according to claim 108 , wherein the entities are labeled.

114 . The method of claim 113 , wherein the entities are optically labeled.

115 . The method of claim 114 , wherein the entities are fluorescently labeled antibodies.

116 . The method of claim 113 , wherein the entities are chemically labeled antibodies.

117 . The method of claim 108 , wherein the first and second droplets are monodisperse with respect to each other.

118 . The method according to claim 108 , wherein the entities are attached to microbeads.

119 . The method according to claim 108 , wherein at least one of the first droplets includes only a single type of entity, present in multiple copies.

120 . The method according to claim 108 , further comprising conducting a reaction in the first droplets.

121 . The method according to claim 120 , further comprising detecting a reaction product in the first droplets.

122 . The method according to claim 121 , wherein said detecting step comprises optically detecting.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2013
From: LINK, DARREN; AHN, KEUNHO; WEITZ, DAVID; BIBETTE, JEROME
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 030216/0030 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 15, 2013
From: GRIFFITHS, ANDREW
To: MEDICAL RESEARCH COUNCIL
Reel/Frame 030216/0064 →